Published on 26/05/2014
In the 1970s, the laboratory extensively participated to scientific research work for developing oral vaccine baits.
A number of experimental trials were undertaken to check efficacy and safety of vaccines before their marketing, in collaboration with other international groups involved in rabies activities. In 1986, the laboratory tested the first available methods of oral vaccination with baits (chicken head baits) deposited in the field by foot distribution. From 1990, the overall organisation of the oral vaccination campaigns has been centralised: the Anses-Nancy Laboratory for rabies and wildlife was requested by the national competent authority to organize and plan the oral vaccination of foxes and, in close cooperation with its delegates, to implement and evaluate the programmes.
From 1988 to 1998, year of the last recorded case of vulpine rabies in France, the laboratory planned the strategy and performed oral vaccination campaigns in infected areas twice a year using helicopters. These campaigns were then prolonged until 2003 along Northern and Eastern borders and were performed once again in 2005.
Several field trials have been conducted to improve the efficiency of oral vaccination programme, particularly to promote cubs' coming into contact with baits and also to counterbalance the increase in the fox population.
Rabies surveillance is the key element of rabies control and prevention programmes. It is based on laboratory investigations on samples taken from susceptible suspect animals to collect sufficient spatial and temporal descriptive data used to build the control programme.
The national network for animal rabies surveillance is centralised at ANSES-Nancy laboratory for rabies and wildlife. The incidence of rabies in animals is currently assessed throughout all the country by undertaking diagnosis on suspect animals using the OIE and WHO reference tests, i.e. the fluorescent antibody test and the cell inoculation test (WHO, 2013; OIE, 2016). The positive cases are systematically investigated by sequencing to characterise the virus strains of isolated lyssaviruses, and also to study the circulating field isolates in the country.
The monitoring of the efficacy of oral vaccination programmes was conducted in vaccinated areas by:..
The laboratory is experienced in the development validation and standardisation of laboratory methods, mainly for diagnosis and serology, and regularly organises international workshops and proficiency tests.
The laboratory is enrolled in a system of quality assurance:
|Standard||Test||Accreditation body||Accreditation date|
|ISO/IEC1704||Rabies serological proficiency test||COFRAC||05 May 2017|
|NF EN ISO/IEC 17025||FAT technique (Lyssavirus antigen)||COFRAC||01 October 2012|
|NF EN ISO/IEC 17025||RTCIT technique (Lyssavirus)||COFRAC||01 October 2012|
|NF EN ISO/IEC 17025||Control of efficacy of live oral vaccines in wildlife||Mutual Joint Audit (EDQM)||30 January 2012|
|NF EN ISO/IEC 17025||Control of efficacy of inactivated rabies vaccines for veterinary and human use||Mutual Joint Audit (EDQM)||05 March 2008|
|NF EN ISO/IEC 17025||Virus seroneutralisation (rabies antibody search)||COFRAC||01 February 2008|
The laboratory has developed the straw sampling technique to facilitate sampling on dead animals for diagnostic analysis. The laboratory has developed and validated a rapid, safe and inexpensive method for collecting brain samples from the field using filter paper (FTA technology) for further analyses by molecular techniques.
Two different techniques have been developed which are currently recommended by WHO and OIE:
A simple procedure has been recently developed by the laboratory allowing simple sampling of blood from foxes and raccoon dogs in field conditions coupled with the use of a reliable ELISA for rabies antibody titration.
For more than 20 years, the laboratory has been in charge of the control of potency of all batches of inactivated rabies vaccines for parenteral use produced or imported in France, by using the NIH test as well as the European Pharmacopoeia test. The laboratory is part of the OMCL (Official Medicine Control Laboratory) network and is involved in OCABR (Official Control Authority Batch Release) of veterinary oral and inactivated rabies vaccines.
The laboratory is also involved in the control of equine immunoglobines intended for post-exposure treatment, adaptation of rabies isolates on cell cultures or mouse and viral titrations in cells and mice.
For several years, molecular tools have been developed (RT-PCR with universal and specific primers, heminested PCR, real time PCR, Southern Blot, nucleotide pyrosequensing, NGS sequencing and phylogenetic analyses) to characterise rabies viruses and to trace spill-over transmissions from reservoir to non-reservoir animals and humans, to possibly detect the emergence of rabies virus variants in new species and geographical areas.
The research work of the laboratory is mainly intended to increase knowledge on the pathogenicity of certain rabies viruses (those that infect European bats), to develop experimental models and to investigate the transmission of bat lyssaviruses to other bats and to non flying animals.
The main current programmes, in close cooperation with other national rabies laboratories, are the following:..
Last update: 09 August 2017
Last update: 20 November 2014